Quotient Clinical
Feb 09, 2017
AMRI enters alliance; Ferring and Enteris deal; Quotient Clinical Acquires; Renova takes over Rights
AMRI enters alliance with Bruker Daltonics and HighRes Biosolutions AMRI has entered an alliance with Bruker Daltonics and HighRes Biosolutions to develop new applications for using high throughput mass spectrometry (MS) for drug discovery. AMRI has acquired the new MALDI PharmaPulse system from Bruker Daltonics and...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
